(Q47831534)

6 February 2018

title

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors (English)

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

31 December 2024

0 references

8

Raine CS

1 reference

6 February 2018

author name string

W. Liedtke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9667591

31 December 2024

B. Cannella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9667591

31 December 2024

R. J. Mazzaccaro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9667591

31 December 2024

J. M. Clements

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9667591

31 December 2024

K. M. Miller

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9667591

31 December 2024

K. W. Wucherpfennig

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9667591

31 December 2024

A. J. Gearing

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9667591

31 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9667591

31 December 2024

publication date

1 July 1998

1 reference

6 February 2018

July 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9667591

full work available at URL

31 December 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410440110

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.410440110

31 December 2024

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

31 December 2024

1 reference

6 February 2018

volume

44

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

35-46

1 reference

6 February 2018

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410440110

Immunological aspects of demyelinating diseases

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

31 December 2024

4

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

31 December 2024

5

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice

31 December 2024

8

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison

31 December 2024

9

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide

31 December 2024

10

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion

31 December 2024

11

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Tumor necrosis factor identified in multiple sclerosis brain

31 December 2024

12

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

31 December 2024

13

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

31 December 2024

14

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

31 December 2024

15

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

31 December 2024

16

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains

31 December 2024

17

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

31 December 2024

18

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

31 December 2024

19

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha

31 December 2024

20

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

31 December 2024

22

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination

31 December 2024

23

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis

31 December 2024

24

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis

31 December 2024

25

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.

31 December 2024

26

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Multiple sclerosis: Fas signaling in oligodendrocyte cell death

31 December 2024

27

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

31 December 2024

28

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Processing of tumour necrosis factor-α precursor by metalloproteinases

31 December 2024

29

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

31 December 2024

30

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases

31 December 2024

31

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

31 December 2024

32

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

31 December 2024

33

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

IL-10 fails to abrogate experimental autoimmune encephalomyelitis

31 December 2024

34

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination

31 December 2024

36

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes

31 December 2024

37

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

A comparison of methods for RNA extraction from lymphocytes for RT-PCR

31 December 2024

38

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Synthesis of RNA probes by the direct in vitro transcription of PCR-generated DNA templates

31 December 2024

40

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones

31 December 2024

42

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases

31 December 2024

44

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

31 December 2024

45

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Multiple sclerosis: Oligodendrocytes display cell death–related molecules in situ but do not undergo apoptosis

31 December 2024

47

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Apoptosis in the nervous system in experimental allergic encephalomyelitis

31 December 2024

48

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Multiple sclerosis: TNF revisited, with promise

31 December 2024

51

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

TNF-alpha- and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function

31 December 2024

52

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta)

31 December 2024

53

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

31 December 2024

54

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

31 December 2024

56

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine

31 December 2024

57

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders

31 December 2024

58

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

31 December 2024

59

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

31 December 2024

60

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

31 December 2024

61

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

31 December 2024

62

1 reference

https://api.crossref.org/works/10.1002/ANA.410440110

31 December 2024

Identifiers

1 reference

6 February 2018

1 reference

6 February 2018